Press
In November 2017, Asana Medical, Inc. announced that they had formally changed their name to Regentys, as a more distinctive representation of their business model and underlying regenerative medicine technology.
Regentys Appoints Dr. Steven D. Wexner Chief Medical Officer
Dec. 7, 2017
Regentys (formerly Asana Medical, Inc.) has named Dr. Steven D. Wexner as its Chief Medical Officer (“CMO”). Dr. Wexner has been a member of the Regentys Medical Advisory Board since January 2014.
Asana Medical, Inc. Announces Corporate Name Change to Regentys
Nov. 28, 2017
MIAMI LAKES, FL – November 28, 2017 -- Asana Medical, Inc., ("Asana"), a regenerative medicine company developing a novel treatment for Ulcerative Colitis (“UC”), is pleased to announce that it has changed its corporate name to Regentys (“Regentys”, the “Company”). The change, which also includes a new corporate logo and branding platform, reflects the Company’s continuing vision and development of its regenerative medicine technologies portfolio, and its lead product, ExtraCellular Matrix Hydrogel (“ECMH”).
Asana Medical, Inc. to Present as Innovation Challenge Finalist at RESI Boston Conference 2017
Sept. 11, 2017
Asana has been selected as an Innovation Challenge Finalist and will present at the RESI Conference in Boston, Massachusetts on Tuesday, September 26th, 2017
Dr. Susan G. Manella Joins Asana’s Medical Advisory Board
Aug. 25, 2017
Dr. Susan G. Manella has accepted the Company’s offer to join its Medical Advisory Board. Dr. Manella will assume the board’s leadership role in managing information flow and liaising between management and medical doctors.
Pharmaceutical Industry Executive Brian W. Andersen Named Chief Business Officer
April 18, 2017
Brian W. Andersen, an experienced industry executive with a proven record of commercial excellence, has been appointed Chief Business Officer.